Magazine Article | May 2, 2022

Platforms To Pipelines: Part 2

Source: Life Science Leader

By Wayne Koberstein, Executive Editor, Life Science Leader magazine
Follow Me On Twitter @WayneKoberstein

Five biopharma company CEOs answered our questions and contributed their thoughts for this article. The companies — Locanabio, BridGene, MorphImmune, Seismic Therapeutic, and Tubulis — all invented their own technology platforms and have since used them to create their own pipelines for development. Having looked at the sequence and significance of the steps each company has taken in that transition, we continue here with views of their future plans, as well as their leaders’ observations of the platform-to-pipeline space they are effectively expanding, by joining a gathering crowd of companies now entering it.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: